scispace - formally typeset
C

Charles M. Perou

Researcher at University of North Carolina at Chapel Hill

Publications -  645
Citations -  235604

Charles M. Perou is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 156, co-authored 573 publications receiving 202951 citations. Previous affiliations of Charles M. Perou include North Carolina Central University & University of Chicago.

Papers
More filters
Journal ArticleDOI

Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer

TL;DR: Improved metastasis-free/progression-free survival was correlated with B-cell gene expression signatures, which were restricted mainly to the basal-like and HER2-enriched breast cancer subtypes and the immunoreactive ovarian cancer subtype, suggesting the presence of a productive and potentially restricted antitumor B- cell response in basal- like breast and immunore active ovarian cancers.
Journal ArticleDOI

Defining the cellular precursors to human breast cancer.

TL;DR: It is reported that transformation of EpCAM+ epithelial cells results in the formation of common forms of human breast cancer, including estrogen receptor-positive and estrogen receptors-negative tumors with luminal and basal-like characteristics, respectively, whereas transformation of CD10+ cells results
Journal ArticleDOI

Merging two gene-expression studies via cross-platform normalization

TL;DR: The proposed normalization method is applied to three existing breast cancer datasets, and is compared to several competing normalization methods using the proposed validation measures.
Journal ArticleDOI

MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11

TL;DR: It is demonstrated that microRNA-30c is transcriptionally regulated by GATA3 in breast tumours and inversely correlates with interleukin-11 expression in primary breast tumour patients, and low interleuko-11 correlates with relapse-free survival in breast cancer patients.
Journal ArticleDOI

The Integrated Genomic Landscape of Thymic Epithelial Tumors

Milan Radovich, +186 more
- 12 Feb 2018 - 
TL;DR: A molecular link between thymoma and the autoimmune disease myasthenia gravis is identified, characterized by tumoral overexpression of muscle autoantigens, and increased aneuploidy.